Guangzhou LBP Medicine Science & Technology Co Ltd (688393) — Capital Reinvestment Ratio
Guangzhou LBP Medicine Science & Technology Co Ltd (688393) has a Capital Reinvestment Ratio of 0.42x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥29.17 Million) in capital expenditures (CN¥12.17 Million). Check tangible equity quality of Guangzhou LBP Medicine Science & Technol to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Guangzhou LBP Medicine Science & Technology Co Ltd Capital Reinvestment Ratio (2012–2024)
This chart tracks Guangzhou LBP Medicine Science & Technology Co Ltd's Capital Reinvestment Ratio across 10 annual periods. For the full cash flow conversion analysis, see Guangzhou LBP Medicine Science & Technol cash flow conversion.
Annual Capital Reinvestment Ratio for Guangzhou LBP Medicine Science & Technology Co Ltd (2012–2024)
Year-by-year Capital Reinvestment Ratio for Guangzhou LBP Medicine Science & Technology Co Ltd from 2012 to 2024. See Guangzhou LBP Medicine Science & Technol (688393) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 6.67x | CN¥3.54 Million | CN¥23.65 Million | ▲ +202.7% |
| 2023 | 2.20x | CN¥17.12 Million | CN¥37.74 Million | ▼ -70.3% |
| 2022 | 7.43x | CN¥9.72 Million | CN¥72.17 Million | ▲ +208.9% |
| 2021 | 2.40x | CN¥59.61 Million | CN¥143.34 Million | ▲ +252.0% |
| 2020 | 0.68x | CN¥91.43 Million | CN¥62.45 Million | ▲ +72.5% |
| 2019 | 0.40x | CN¥89.74 Million | CN¥35.54 Million | ▼ -41.1% |
| 2018 | 0.67x | CN¥65.35 Million | CN¥43.92 Million | ▲ +68.7% |
| 2017 | 0.40x | CN¥83.92 Million | CN¥33.43 Million | ▲ +9.4% |
| 2016 | 0.36x | CN¥43.37 Million | CN¥15.79 Million | ▼ -88.5% |
| 2012 | 3.15x | CN¥4.84 Million | CN¥15.25 Million | — |